logo
Loading...
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader

Medicine and Health

Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader

A. V. Carmona, S. Jonnalagadda, et al.

Discover the groundbreaking research by Angelica V. Carmona and colleagues on the first-in-class AKR1C3 PROTAC degrader that shows promise in targeting prostate cancer by reducing AKR1C3 expression and degrading ARv7. This innovative approach could change the landscape of prostate cancer treatment.... show more
Citation Metrics
Citations
11
Influential Citations
0
Reference Count
44
Citation by Year

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny